back to events
Aurobindo Pharma Responds to USFDA Quality Concerns
regulatory_filingNegative
confidence: 100%
Description
NSE sought clarification from Aurobindo Pharma Limited following media reports of USFDA quality concerns at its Telangana plant and a subsequent drop in share price.